tiprankstipranks
ReShape Lifesciences (RSLS)
NASDAQ:RSLS
US Market

ReShape Lifesciences (RSLS) Cash flow

Compare
476 Followers

ReShape Lifesciences Cash Flow

RSLS's free cash flow for Q3 2024 was $-311.00K. For the 2024 fiscal year, RSLS's free cash flow was decreased by $5.03M and operating cash flow was $-311.00K. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -16.96M$ -21.90M$ -15.38M$ -8.55M$ -14.20M
Investing Cash Flow
$ -10.00K$ -92.00K$ 1.85M$ -2.39M$ -2.01M
Financing Cash Flow
$ 17.57M$ 3.13M$ 33.30M$ 11.07M$ 13.66M
End Cash Position
$ 4.56M$ 3.96M$ 22.82M$ 3.01M$ 2.98M
Free Cash Flow
$ -17.00M$ -22.03M$ -15.73M$ -8.94M$ -14.21M
Currency in USD

ReShape Lifesciences Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis